We are thrilled to share groundbreaking clinical data on our JuxtaFlow® Renal Assist Device (RAD), unveiled at the Society of Thoracic Surgeons (STS) Perioperative Care Meeting in Philadelphia. Our BIPASS-AKI Feasibility Study not only met its objectives but showcased the potential of the JuxtaFlow RAD to sustain renal function post-cardiac surgery with cardiopulmonary bypass. Presented by Dr. Evelio Rodriguez, these findings pave the way to a pivotal trial. For more details on our study and innovations, check out the full press release on PR Newswire: https://lnkd.in/ezi3Kv4q #Roivios #JuxtaFlowRAD #RenalHealth #CardiacSurgery #HealthcareAdvancement #MedicalInnovation #KidneyHealth #HealthcareInnovation #MedicalDevices #RenalCare #PatientOutcomes #InnovationInHealthcare #KidneyDisease #Nephrology #ProtectTheKidney
Congratulations!
Managing Partner at SeaCrest Capital Partners
1moCongratulations!